SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001408408-20-000027
Filing Date
2020-06-18
Accepted
2020-06-18 16:42:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A ecl_mrkr13da06182020.htm SC 13D/A 50731
2 EX.1 ecl_mrkr13dex1.htm EX-1 6780
3 EX 2.1 ecl_mrkr13dex21.htm EX-2 1770
4 EX 2.2 ecl_mrkr13dex22.htm EX-2 1566
5 EX 3 ecl_mrkr13dex3.htm EX-3 1524
6 EX 4 ecl_mrkr13dex4.htm EX-4 1462
  Complete submission text file 0001408408-20-000027.txt   65623
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Subject) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58217 | Film No.: 20973200
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006
Business Address 10 MARKET STREET, #773 CAMANA BAY GRAND CAYMAN E9 KY1-9006 345-640-3300
Eastern Capital LTD (Filed by) CIK: 0001408408 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A